Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported quarterly EPS; no daily interpolation. Q4 FY2025 (2025-12-31): -0.05.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
-0.05
EARNINGS PER SHARE (EPS) AVG 3Y
-0.06
EARNINGS PER SHARE (EPS) AVG 5Y
-0.06
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Jyong Biotech Ltd. Ordinary Shares
Market Cap
$155.86M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.05
3Y Avg
-0.06
5Y Avg
-0.06
Market Cap
$155.42M
Earnings Per Share (EPS)
-1.13
TTM Avg
-2.24
3Y Avg
-2.81
5Y Avg
-2.43
Market Cap
$158.30M
Earnings Per Share (EPS)
-0.90
TTM Avg
-1.19
3Y Avg
-2.61
5Y Avg
-1.83
Market Cap
$152.17M
Earnings Per Share (EPS)
-0.26
TTM Avg
-0.32
3Y Avg
-0.33
5Y Avg
-0.37
Market Cap
$158.63M
Earnings Per Share (EPS)
-28.87
TTM Avg
-17.24
3Y Avg
-11.28
5Y Avg
-9.01
Market Cap
$151.98M
Earnings Per Share (EPS)
-0.26
TTM Avg
-0.53
3Y Avg
-0.57
5Y Avg
-0.55
Market Cap
$151.10M
Earnings Per Share (EPS)
-0.34
TTM Avg
-0.70
3Y Avg
-0.76
5Y Avg
-0.63
Market Cap
$149.15M
Earnings Per Share (EPS)
-1.64
TTM Avg
-1.85
3Y Avg
-1.46
5Y Avg
-1.46
Market Cap
$162.20M
Earnings Per Share (EPS)
-1.50
TTM Avg
-2.49
3Y Avg
-3.17
5Y Avg
-2.41
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jyong Biotech Ltd. Ordinary Shares (MENS) | $155.86M | N/A | -0.05 | -0.06 | -0.06 |
| ALX Oncology Holdings Inc. (ALXO)vs › | $155.42M | -1.13 | -2.24 | -2.81 | -2.43 |
| Inogen, Inc. (INGN)vs › | $158.30M | -0.90 | -1.19 | -2.61 | -1.83 |
| Cardiol Therapeutics Inc. (CRDL)vs › | $152.17M | -0.26 | -0.32 | -0.33 | -0.37 |
| Minerva Neurosciences, Inc. (NERV)vs › | $158.63M | -28.87 | -17.24 | -11.28 | -9.01 |
| Anavex Life Sciences Corp. (AVXL)vs › | $151.98M | -0.26 | -0.53 | -0.57 | -0.55 |
| Codexis, Inc. (CDXS)vs › | $151.10M | -0.34 | -0.70 | -0.76 | -0.63 |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $149.15M | -1.64 | -1.85 | -1.46 | -1.46 |
| PepGen Inc. (PEPG)vs › | $162.20M | -1.50 | -2.49 | -3.17 | -2.41 |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $148.36M | -0.61 | -0.35 | -0.32 | -0.30 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.06 |
| 2024-12-31 | -0.04 |
| 2023-12-31 | -0.06 |
| 2022-12-31 | -0.09 |
| 2021-12-31 | -0.06 |
| 2020-12-31 | -0.03 |
